Skip to main content
. 2024 Jan 15;14:1286771. doi: 10.3389/fimmu.2023.1286771

Figure 4.

Figure 4

Kaplan−Meier (KM) analysis of ECC patients receiving the combination therapy of interventional treatment plus lenvatinib with or without PD-1 inhibitor. (A) the KM analysis of overall survival time before PSM analysis; (B) the KM analysis of time to progression before PSM analysis; (C) the KM analysis of overall survival time after PSM analysis; (D) the KM analysis of time to progression after PSM analysis. SI, biliary stenting implantation with iodine-125 seed strand; HAIC, hepatic artery infusion chemotherapy; PD-1, programmed death-1; ECC, extrahepatic cholangiocarcinoma; PSM, propensity-matched.